Investor List:

Top Pharmaceuticals Series B Investors in Midwest (42)

Know someone who's actively diligencing and investing? Add them to this list.
About this list
We’ve compiled a list of the top Pharmaceuticals investors. The goal is to help Founders find the best investors to target and get introduced to.
Photo of Cam Doody, Partner at Brickyard
Cam Doody
Brickyard·Partner
Sweet spot: $1.5M
Range: $100K - $5.0M
Investors in Chattanooga (TN)
Investors in Pharmaceuticals (Series B), Investors in Digital Health (Series B), Investors in Medical Devices (Series B), Investors in Hardware (Series B), Investors in Health & Hospital Services (Series B), Investors in Pharmaceuticals (Series A), Investors in Pharmaceuticals (Seed), Investors in Health IT (Series B), Investors in Medical Devices (Series A), Investors in Hardware (Series A), Investors in Medical Devices (Seed), Investors in Digital Health (Series A), Investors in Hardware (Seed), Investors in Digital Health (Seed), Investors in Health & Hospital Services (Series A), Investors in Health & Hospital Services (Seed), Investors in Health IT (Series A), Investors in Health IT (Seed), Investors in Medical Devices (Series B), Investors in Pharmaceuticals (Series B), Investors in Hardware (Series B), Investors in Medical Devices (Series A), Investors in Pharmaceuticals (Series A), Investors in Medical Devices (Seed), Investors in Pharmaceuticals (Seed), Investors in Hardware (Series A), Investors in Midwest (Other Lists), Investors in Digital Health (Series B), Investors in Hardware (Seed), Investors in Health & Hospital Services (Series B), Investors in Health IT (Series B), Investors in Digital Health (Series A), Investors in Digital Health (Seed), Investors in Health & Hospital Services (Series A), Investors in Health & Hospital Services (Seed), Investors in Health IT (Series A), Investors in Health IT (Seed)
to see your intro paths to Cam
Photo of Matt McGauley, Investor at Brickyard
Matt McGauley
Brickyard·Investor
Sweet spot: $1.5M
Range: $100K - $5.0M
Investors in Chattanooga (TN)
Investors in Pharmaceuticals (Series B), Investors in BioTech (Series B), Investors in Medical Devices (Series B), Investors in Digital Health (Series B), Investors in Hardware (Series B), Investors in Health & Hospital Services (Series B), Investors in Pharmaceuticals (Series A), Investors in Pharmaceuticals (Seed), Investors in Health IT (Series B), Investors in Hardware (Series A), Investors in Medical Devices (Series A), Investors in Medical Devices (Seed), Investors in Digital Health (Series A), Investors in Hardware (Seed), Investors in Digital Health (Seed), Investors in BioTech (Series A), Investors in Health & Hospital Services (Series A), Investors in Health & Hospital Services (Seed), Investors in BioTech (Seed), Investors in Health IT (Series A), Investors in Health IT (Seed), Investors in Medical Devices (Series B), Investors in Pharmaceuticals (Series B), Investors in Hardware (Series B), Investors in Medical Devices (Series A), Investors in Pharmaceuticals (Series A), Investors in Pharmaceuticals (Seed), Investors in Medical Devices (Seed), Investors in Hardware (Series A), Investors in Digital Health (Series B), Investors in Hardware (Seed), Investors in BioTech (Series B), Investors in Health & Hospital Services (Series B), Investors in Health IT (Series B), Investors in Digital Health (Series A), Investors in Digital Health (Seed), Investors in BioTech (Series A), Investors in Midwest (Other Lists), Investors in Health & Hospital Services (Series A), Investors in BioTech (Seed), Investors in Health & Hospital Services (Seed), Investors in Health IT (Series A), Investors in Health IT (Seed)
to see your intro paths to Matt
Photo of William Schmidt, General Partner at Cultivation Capital
William Schmidt
Cultivation Capital·General Partner
Sweet spot: $1.8M
Range: $100K - $3.5M
Investors in St. Louis (MO)
Investors in Pharmaceuticals (Series B), Investors in Medical Devices (Series B), Investors in BioTech (Series B), Investors in Pharmaceuticals (Series A), Investors in Pharmaceuticals (Seed), Investors in Medical Devices (Series A), Investors in Medical Devices (Seed), Investors in BioTech (Seed), Investors in BioTech (Series A), Investors in Health IT (Series A), Investors in Health IT (Series B), Investors in Health IT (Seed), Investors in Pharmaceuticals (Series B), Investors in Medical Devices (Series B), Investors in Medical Devices (Seed), Investors in Pharmaceuticals (Series A), Investors in Medical Devices (Series A), Investors in Pharmaceuticals (Seed), Investors in BioTech (Series B), Investors in Health IT (Series B), Investors in Midwest (Other Lists), Investors in BioTech (Series A), Investors in BioTech (Seed), Investors in Health IT (Seed), Investors in Health IT (Series A)
to see your intro paths to William
Photo of Jeff Aiello, Managing Director at Thompson Street Capital Partners
Jeff Aiello
Sweet spot: $25.0M
Range: $5.0M - $50.0M
Investors in St. Louis (MO)
Investors in Enterprise Infrastructure (Series B), Investors in Pharmaceuticals (Series B), Investors in Enterprise Applications (Series B), Investors in Consumer Health (Series B), Investors in Medical Devices (Series B), Investors in BioTech (Series B), Investors in AI (Series B), Investors in Enterprise (Series B), Investors in Digital Health (Series B), Investors in Health IT (Series B), Investors in Medical Devices (Series B), Investors in Pharmaceuticals (Series B), Investors in Enterprise Infrastructure (Series B), Investors in Enterprise Applications (Series B), Investors in Consumer Health (Series B), Investors in Digital Health (Series B), Investors in BioTech (Series B), Investors in Midwest (Other Lists), Investors in AI (Series B), Investors in Health IT (Series B), Investors in Enterprise (Series B)
to see your intro paths to Jeff
Photo of Ray Wagner, Managing Director at Thompson Street Capital Partners
Ray Wagner
Sweet spot: $25.0M
Range: $5.0M - $50.0M
Investors in St. Louis (MO)
Investors in Pharmaceuticals (Series B), Investors in Consumer Internet (Series B), Investors in Consumer Health (Series B), Investors in Medical Devices (Series B), Investors in AI (Series B), Investors in BioTech (Series B), Investors in Digital Health (Series B), Investors in Enterprise (Series B), Investors in Health & Hospital Services (Series B), Investors in Health IT (Series B), Investors in Medical Devices (Series B), Investors in Pharmaceuticals (Series B), Investors in Consumer Health (Series B), Investors in Digital Health (Series B), Investors in Health & Hospital Services (Series B), Investors in BioTech (Series B), Investors in AI (Series B), Investors in Health IT (Series B), Investors in Midwest (Other Lists), Investors in Consumer Internet (Series B), Investors in Enterprise (Series B)
to see your intro paths to Ray
Photo of Rick Clifton, Managing Director at Thompson Street Capital Partners
Rick Clifton
Sweet spot: $25.0M
Range: $5.0M - $50.0M
Investors in St. Louis (MO)
Investors in Pharmaceuticals (Series B), Investors in ClimateTech/CleanTech (Series B), Investors in Consumer Health (Series B), Investors in Medical Devices (Series B), Investors in AI (Series B), Investors in BioTech (Series B), Investors in Health & Hospital Services (Series B), Investors in Digital Health (Series B), Investors in Enterprise (Series B), Investors in Health IT (Series B), Investors in Medical Devices (Series B), Investors in Pharmaceuticals (Series B), Investors in ClimateTech/CleanTech (Series B), Investors in Consumer Health (Series B), Investors in Digital Health (Series B), Investors in BioTech (Series B), Investors in AI (Series B), Investors in Health & Hospital Services (Series B), Investors in Health IT (Series B), Investors in Midwest (Other Lists), Investors in Enterprise (Series B)
to see your intro paths to Rick
Photo of Brian Kornmann, Managing Director at Thompson Street Capital Partners
Brian Kornmann
Sweet spot: $25.0M
Range: $5.0M - $50.0M
Investors in St. Louis (MO)
Investors in Pharmaceuticals (Series B), Investors in Consumer Health (Series B), Investors in Enterprise Applications (Series B), Investors in Digital Health (Series B), Investors in Consumer Internet (Series B), Investors in Health & Hospital Services (Series B), Investors in Medical Devices (Series B), Investors in BioTech (Series B), Investors in Health IT (Series B), Investors in Enterprise (Series B), Investors in Pharmaceuticals (Series B), Investors in Medical Devices (Series B), Investors in Midwest (Other Lists), Investors in Enterprise Applications (Series B), Investors in Consumer Health (Series B), Investors in Digital Health (Series B), Investors in BioTech (Series B), Investors in Health IT (Series B), Investors in Health & Hospital Services (Series B), Investors in Consumer Internet (Series B), Investors in Enterprise (Series B)
to see your intro paths to Brian
Photo of Bob Dunn, Managing Partner at Thompson Street Capital Partners
Bob Dunn
Sweet spot: $25.0M
Range: $5.0M - $50.0M
Investors in St. Louis (MO)
Investors in Pharmaceuticals (Series B), Investors in Consumer Health (Series B), Investors in Digital Health (Series B), Investors in Enterprise Infrastructure (Series B), Investors in Consumer Internet (Series B), Investors in Medical Devices (Series B), Investors in BioTech (Series B), Investors in Enterprise (Series B), Investors in Health & Hospital Services (Series B), Investors in Health IT (Series B), Investors in Medical Devices (Series B), Investors in Pharmaceuticals (Series B), Investors in Enterprise Infrastructure (Series B), Investors in Midwest (Other Lists), Investors in Consumer Health (Series B), Investors in Health & Hospital Services (Series B), Investors in Digital Health (Series B), Investors in BioTech (Series B), Investors in Health IT (Series B), Investors in Consumer Internet (Series B), Investors in Enterprise (Series B)
to see your intro paths to Bob
Get new data & insights delivered to your inbox
Firms investing in this space